Clostridioides difficile

Clostridioides difficile is a bacterium that can cause severe diarrhea and colitis, particularly in individuals who have recently taken antibiotics. This microorganism is significant because it is a leading cause of hospital-acquired infections and can be difficult to treat.

Several studies highlight the structural and functional aspects of C. difficile. Research has detailed how the bacterium's flagella play a crucial role in its motility, which aids in colonizing the gut. Additionally, modifications to the peptidoglycan layer of the bacterial cell wall have been linked to antibiotic resistance and survival in harsh environments. The spore coat assembly and formation processes are also critical for the bacterium's ability to persist and spread in healthcare settings.

C. difficile is closely associated with antibiotic use and hospital-acquired infections, which can lead to significant morbidity and mortality. Strategies for preventing and treating C. difficile infections include optimizing antibiotic stewardship, enhancing infection control measures, and exploring new therapeutic options such as fecal microbiota transplantation.

While these studies provide valuable insights, more research is needed to fully understand the complex mechanisms of C. difficile and to develop effective interventions.

Sources

• .Clostridioides difficile. (PMID:30297117)
• Clostridioides difficile Flagella. (PMID:38396876)
• Clostridioides difficile Colitis. (PMID:38677819)
• Clostridioides difficile peptidoglycan modifications. (PMID:34883390)
• Clostridioides difficile Infections: Prevention and Treatment Strategies. (PMID:39060738)
• Clostridioides difficile spore: coat assembly and formation. (PMID:36032037)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._